SLC27A5, also known as FATP5, is associated with progression and hepatic fat loss in NAFLD patients, in whom a reduction in hepatic FATP5 expression is inversely correlated with histological markers of progression. The gene discussed is SLC27A5; the disease is metabolic dysfunction-associated steatotic liver disease.